Thrombocytopenic Purpura Immune


Article Author:
Angel Justiz Vaillant


Article Editor:
Nagendra Gupta


Editors In Chief:
Dustin Constant
Donald Kushner


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
6/18/2019 7:08:12 PM

Introduction

Immune thrombocytopenic purpura (ITP) is an autoimmune pathology characterized by a low platelet count, purpura and hemorrhagic episodes caused by antiplatelet autoantibodies. The diagnosis is typically made by the exclusion of the known causes of thrombocytopenia. IgG autoantibodies sensitize the circulating platelets. It leads to accelerated removal of these cells by antigen-presenting cells (macrophages) of the spleen, and sometimes the liver or other components of the monocyte-macrophage system. Bone marrow compensates the platelet destruction by increasing platelet production. ITP most often occurs in healthy children and young adults within a few weeks following a viral infection. ITP is usually manageable with immunosuppressive therapy.[1][2] An identical form of autoimmune thrombocytopenia can also be associated with chronic lymphocytic leukemia, lymphomas, SLE, infectious mononucleosis and other bacterial and viral infections. Certain drugs can also cause immune thrombocytopenia indistinguishable from ITP. Most children have spontaneous remission within a few weeks or months, and splenectomy is rarely needed. However young adults rarely have spontaneous remissions necessitating splenectomy within the first few months after diagnosis.

Etiology

ITP can occur with infections (e.g., human immunodeficiency virus), malignancy (e.g., adenocarcinoma and lymphoma), and common variable immunodeficiency and autoimmune diseases (e.g., systemic lupus erythematosus, autoimmune hepatitis, and thyroid disease).[3] Somehow in these diseases, there is a formation of anti-platelet antibodies leading to platelet destruction. Drugs may also cause autoimmune thrombocytopenia, for example, acetazolamide, aspirin, aminosalicylic acid, carbamazepine, cephalothin, digitoxin, phenytoin, meprobamate, methyldopa, quinidine, rifampin, and sulfamethazine. 

Epidemiology

ITP can be divided into two classifications; acute and chronic. The acute form presents in childhood, affects both sexes and may be prefaced by a viral infection. Most children (85%) have a benign course and do not require treatment. They can spontaneously recover within three months. The chronic form affects individuals between ages 20-50 years; there is a female/male ratio of 3:1 and It is usually not preceded by a viral infection. It may present with episodes of bleeding by months or years, during that time the platelet counts are close to normal. Fewer than 10% of children develop chronic ITP.

HIV-associated disease is now the most common cause of thrombocytopenic purpura, especially in males between 20 and 50 years of age. Testing for HIV antibodies is a critical part of the assessment of ITP.[4][5]

Pathophysiology

The spleen is an essential site of autoantibody production. Sequestration of anti-platelet IgG antibodies takes place in the spleen's red pulp, where sensitized platelet removal occurs by phagocytosis. Research showed that radiolabeled-IgG sensitized platelets removal occurs in few hours compared with a normal platelet half-life of 8-9 days.[2]

Neonatal alloimmune thrombocytopenia may occur in pregnant women who are negative for the platelet antigen PL a1 but were sensitized in prior pregnancies by infants who were PL a1 positive or by blood transfusion. The condition has also involved other platelet antigens.[6]

In drug-induced ITP, the drug absorbs on the platelet cell membrane. The immune system makes antibodies to the target drug-platelet complex, which results in the removal of the sensitized platelet by phagocytes residing in spleen and liver. The activation of the complement system by the classical pathway is another effector mechanism of platelet cell damage (thrombocytopenia).[7] 

Childhood immune thrombocytopenic purpura often occurs within a few weeks following a viral infection, suggesting a possible cross-immunization between viral and platelet antigens, the absorption of immune complexes, or a hapten mechanism.

Many other platelet antigens are a target of autoantibodies, including GPIIb/IIIA and GP V (after chickenpox).

Histopathology

Histopathology of immune thrombocytopenic purpura can often reveal the finding of increased production of megakaryocytes in the bone marrow.[8] This finding suggests that the thrombocytopenia is secondary to increased platelet destruction rather than decreased platelet formation. Harrington and coworkers first showed in 1951 that the plasma from a patient with immune thrombocytopenic purpura caused thrombocytopenia when transfused into a healthy subject.

History and Physical

There may be a history of drugs use, a viral infection or immunization. The acute ITP can be characterized by generalized purpura in a previously healthy child or less commonly in an adult, bruises following minor trauma, the presence of oral hemorrhagic bullae, epistaxis, gastrointestinal bleeding, conjunctival hemorrhage, and hematuria. More commonly the illness is gradual in onset but chronic in the course.

The chronic ITP may be characterized by insidious onset or suddenly becomes acute. It is seen more common in females and presents with scattered petechiae, epistasis and menorrhagia, episodes of bleeding separated by a long period and occasionally these clinical findings can be due to HIV-related illness.

Evaluation

The laboratory tests will show:

  • Low platelet count, usually <40x10^9/L for over three months.
  • Blood film: It shows large platelets and tiny platelet fragments.
  • Bone marrow examination: It shows an increased number of megakaryocytes.
  • Platelet Coomb's test: Detects anti-platelet antibodies fixed on the patient's platelets.
  • Indirect test: Uses a pool of normal donor platelets to detect free serum antibodies against platelets, usually anti-glycoprotein IIb/IIIa antibodies. 
  • Various other tests can be used to detect anti-platelet antibodies including lymphocyte activation by autologous platelets, lymphocyte activation by platelet-antibody immune complexes, phagocytosis of platelet-associated IgG by competitive binding assays, radiolabeled Coombs antiglobulin test, fluorescein-labeled Coombs antiglobulin, and ELISA. 

Testing for systemic lupus erythematosus (presenting with ITP):

  • Antinuclear antibodies (ANA), can be performed using indirect immunofluorescence. Most cases of SLE show positive ANA results. 
  • Testing for auto-antibodies: This includes testing for anti-double-stranded DNA (anti-dsDNA), anti-Smith, ENA, anti-cardiolipin, and anti-beta2 GP-I antibodies. A high serum level of anti-dsDNA and anti-Smith antibodies suggests SLE.   
  • Additionally, detection of C3 and C4, immunoglobulins (IgM, IgG, and IgA), serum protein electrophoresis, and cryoglobulins (if Raynaud's is present) may be performed.
  • Biopsies (lupus band test): Shows deposits of IgG and C3/C4 along the dermo-epidermal junction in a lumpy-bumpy distribution. Renal biopsy may be helpful. It shows deposition of immunocomplexes in the glomeruli. 

Treatment / Management

The management of ITP involves the following[9][1][10]

  • Aim to bring the platelet count to be normal.  
  • Indication for active therapy is only when there is acute bleeding.  
  • The vast majority of children recover spontaneously without sequelae. In severe cases, the treatment of choice is intravenous immunoglobulin (IV IgG). A 5-day course of 400 mg/kg/d is given. Responses occur in more than 70% in 1-4 days, but only for a short period many patients respond, and repeated courses may be necessary.  
  • Adults require treatment if platelet count is below 40x10^9/L.   
  • Patients (children and adults) with active bleeding require corticosteroids to stop further destruction of platelets (about 60% of patients respond well within two weeks). 
  • Patients who do not respond adequately and have active bleeding after a month of being treated with corticosteroids may need splenectomy, after using intravenous immunoglobulins to raise the platelet count. Therefore, splenectomy is the treatment of choice for adult patients with ITP who have persistent symptomatic thrombocytopenia.
  • In adults patients with ITP, the corticosteroid preferred is prednisone 1-2 mg/kg/d.  
  • It reserves plasmapheresis for cases of fulminant ITP.  
  • Neonatal thrombocytopenia is treatable with intravenous immunoglobulin which raises the platelet count.
  • Platelets increase after three months in untreated ITP neonates, due to the catabolism of maternal anti-platelet antibody that was transferred during birth.  
  • Vincristine seems to be a valuable drug in adult patients that do not respond to splenectomy.
  • Zidovudine is effective in raising platelet counts in individuals with HIV-associated immune thrombocytopenic purpura.

Differential Diagnosis

One should consider thrombocytopenias due to increased platelet destruction and those due to platelet production.[1][11][12]

Thrombocytopenias due to increased platelet destruction include:

Immune thrombocytopenia

  • Idiopathic thrombocytopenic purpura
  • Secondary autoimmune thrombocytopenias
  • Drug-induced immune thrombocytopenias
  • Posttransfusion purpura
  • Neonatal immune thrombocytopenias
  • Thrombocytopenias due to use of factor VIII concentrate
  • HIV infection

Consumptive thrombocytopenias

  • Thrombotic thrombocytopenic purpura 
  • Disseminated intravascular coagulation (DIC)
  • Hemolytic-uremic syndrome
  • Vasculitis
  • Sepsis 

Hypersplenism

Thrombocytopenias due to decreased platelet production

  • Bone marrow suppression by drugs, alcohol, toxins, and infections 
  • Aplastic anemia 
  • Leukemias and other bone marrow cancers   
  • Megaloblastic anemia   
  • Refractory anemias, preleukemia, and hematopoietic dysplasia 

Prognosis

Prognosis is good for acute ITP since most patients make a spontaneous recovery. Patients with chronic ITP almost always require treatment and relapse commonly occurs. Complete response to the first-line steroid can occur about 20% of the patients, and about 60% have a partial response. Vincristine is used in adult patients that do not respond to splenectomy.

Complications

The most severe complication of ITP is hemorrhage, especially bleeding into the brain that may prove fatal. 

Deterrence and Patient Education

The general practitioner can assess the bleeding and make recommendations about the management, and also a referral to a specialist (hematologist). Adults should remain compliant with medications. 

Pearls and Other Issues

  • The definition of thrombocytopenia is when the blood platelet count is < 150x10^9/L. It may not be symptomatic until the platelet count falls below 10x10^9/L.  
  • ITP can be idiopathic, although it is often autoimmune-related.   
  • ITP can be secondary to SLE, HIV, and drugs (e.g., quinine).   
  • The antibody involved is not temperature dependent and always directed against platelet-specific antigens.    
  • Corticosteroids work by decreasing phagocytosis of antibody-coated platelet by phagocytes in both spleen and liver.   
  • Splenectomy removes the sites of autoantibody production and phagocytosis and is successful in most patients.    
  • In refractory patients, one can successfully use intravenous immunoglobulins. The IgG blocks Fc-receptors on macrophages and reduces platelet binding to autoantibodies.

Enhancing Healthcare Team Outcomes

An interdisciplinary team should manage the patient with ITP. The clinician and nursing staff may monitor subjects with a less severe disease if it does not involve important organ systems. The clinician should refer patients with complications to a hematologist, which can coordinate closely with the patient's clinician to maximize management and progress. The pharmacist should be involved in the coordination of drug therapy and monitoring for complications.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Thrombocytopenic Purpura Immune - Questions

Take a quiz of the questions on this article.

Take Quiz
What is the initial treatment for a patient with immune thrombocytopenic purpura?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which is true about immune thrombocytopenic purpura (ITP)?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 17-year-old presents with a 3-week history of petechiae and bruising on his trunk. He had an upper respiratory tract infection about 4 weeks ago and soon after noticed the bruising. Blood work revealed that he had a very low platelet count and was positive for anti-platelet antibodies. What is the best course of treatment for this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 14-year-old presents with multiple bruises. He had an upper respiratory tract infection a few weeks ago and is suspected of having immune thrombocytopenic purpura (ITP). Which of the following laboratory findings is correct about ITP?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not a laboratory finding in immune thrombocytopenic purpura (ITP)?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient with immune thrombocytopenic purpura will have an abnormality in which of the following?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 5-year-old child presents with recurrent nose bleeding. He is otherwise well. Which of the following is the best initial investigation needed for this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 5-year-old patient was found to have a platelet count of 40,000/microliter. He does not have active bleeding. His coagulation profile is normal. Which of the following tests can be performed before proceeding to treatment?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is true about acute immune thrombocytopenic purpura (ITP) in children?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following investigations is sufficient to make a presumed diagnosis of acute thrombotic thrombocytopenic purpura?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Two weeks after an adenoviral infection, a child develops a localized purpura. Antiplatelet IgG is present at a high titer. Which of the following is the most likely diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following would be the most common cause of a rash with very small, bright red, nonblanching macules preceded by a nonspecific viral syndrome in a teenager who is in otherwise excellent health?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following causes autoimmune platelet destruction?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 17-year-old patient without medical history presents with a petechial rash on both legs and mild gingival bleeding with tooth brushing. She is on no medications, does not drink or smoke and has an otherwise normal exam; her platelet count is 10,000/microliter, but hematocrit and WBC count are normal. What is the best treatment?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which is true regarding immune thrombocytopenic purpura (ITP)?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 3-year-old male develops generalized petechiae and bruising mostly on the legs about 14 days after a viral syndrome. There is no lymphadenopathy or hepatosplenomegaly. No other physical findings are noted. CBC shows normal hematocrit, white blood cells, and differential. Platelets are low at 20,000. Select the most likely diagnosis.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Thrombocytopenic Purpura Immune - References

References

Matzdorff A,Wörmann B, [Diagnosis and Therapy of Immune thrombocytopenia]. Deutsche medizinische Wochenschrift (1946). 2018 Aug     [PubMed]
Karakurt N,Uslu İ,Albayrak C,Tomak L,Ozyazici E,Albayrak D,Aygun C, Neonates born to mothers with immune thrombocytopenia: 11 years experience of a single academic center. Blood coagulation     [PubMed]
Swinkels M,Rijkers M,Voorberg J,Vidarsson G,Leebeek FWG,Jansen AJG, Emerging Concepts in Immune Thrombocytopenia. Frontiers in immunology. 2018     [PubMed]
Poles A,Lucas G,Green F,Walser P,Davey S,Ridgwell K,Wylie P, Neonatal alloimmune thrombocytopenia due to a new alloantigen Bl(a) defined by an Asp458Gly substitution in GPIIIa. Transfusion. 2018 Nov 29     [PubMed]
Alzahrani M,Alrumaih I,Alhamad F,Abdel Warith A, Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature. Platelets. 2018 Sep     [PubMed]
Vrbensky JR,Nazy I,Toltl LJ,Ross C,Ivetic N,Smith JW,Kelton JG,Arnold DM, Megakaryocyte apoptosis in immune thrombocytopenia. Platelets. 2018 Nov     [PubMed]
Apte S,Navarro-Puerto J,Damodar S,Ramanan V,John J,Kato G,Ross C,Shah C,Torres M,Fu C',Rucker K,Pinciaro P,Barrera G,Aragonés ME,Ayguasanosa J, Safety and efficacy of intravenous immunoglobulin (Flebogamma{sup}®{/sup} 10% DIF) in patients with immune thrombocytopenic purpura. Immunotherapy. 2018 Nov 30     [PubMed]
George JN, Sequence of treatments for adults with primary immune thrombocytopenia. American journal of hematology. 2012 May     [PubMed]
Lee AC, Isolated thrombocytopenia in childhood: what if it is not immune thrombocytopenia? Singapore medical journal. 2018 Jul     [PubMed]
Sundin M,Marits P,Nierkens S,Kolios AGA,Nilsson J,     [PubMed]
Ponzetto A,Figura N,Fiorini G, Immune thrombocytopenic purpura and infections. Internal and emergency medicine. 2018 Oct;     [PubMed]
Okazaki M,Nakamura M,Imai A,Asagiri T,Takeuchi S, Sequential occurrence of Graves' disease and immune thrombocytopenic purpura as manifestations of immune reconstitution inflammatory syndrome in an HIV-infected patient. International journal of STD     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Podiatry Cert Medicine. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Podiatry Cert Medicine, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Podiatry Cert Medicine, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Podiatry Cert Medicine. When it is time for the Surgery-Podiatry Cert Medicine board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Podiatry Cert Medicine.